Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (14,979) $ (15,179)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 4,197 3,492
Amortization and write off of debt issuance cost 283 33
Amortization of discount on long-term debt 609 151
Change in contingent consideration from acquisitions 15,742 9,546
Amortization of right-of-use assets 1,212 469
Bad debt recovery (21) (617)
Equity based compensation 6,056 15,248
Non Cash Interest (478) (208)
Gain on disposal of assets 0 43
Changes in assets and liabilities:    
Accounts receivable 3,230 (3,300)
Inventories (2,098) (2,289)
Prepaid expenses and other current assets (3,083) (2,117)
Operating lease liabilities (1,228) (489)
Deferred costs 138 (818)
Notes receivable, net 2 5
Accounts payable 2,794 (2,758)
Accrued expenses 433 (4,633)
Other current liabilities (1,800) 20
Deferred revenue 624 5,924
Other assets (68) (10)
Other liabilities (214) 461
Net cash provided by operating activities 11,351 2,888
Cash flows from investing activities:    
Purchases of property and equipment (2,127) (1,798)
Proceeds from sale of assets 0 65
Purchase of intangible assets (470) (316)
Notes receivable issued 0 (585)
Notes receivable payments received 212 426
Net cash used in investing activities (2,385) (2,208)
Cash flows from financing activities:    
Borrowings from long-term debt 126,100 0
Payments on long-term debt (1,065) (740)
Debt issuance costs (115) (46)
Payment of preferred stock dividend and deemed dividend (1,320) (4,875)
Payment of contingent consideration 0 (589)
Payments for taxes related to net share settlement of restricted share units (7,935) 0
Payments for redemption of preferred stock (130,766) 0
Loan to shareholder (Note 10) (3,100) 0
Net cash used in financing activities (18,201) (6,250)
Decrease in cash, cash equivalents and restricted cash (9,235) (5,570)
Cash, cash equivalents and restricted cash, beginning of period 37,370 21,320
Cash, cash equivalents and restricted cash, end of period 28,135 15,750
Supplemental cash flow information:    
Interest paid 7,036 2,499
Income taxes paid 550 146
Noncash investing and financing activity:    
Capital expenditures accrued 1,169 807
Adjustment of convertible preferred stock to redemption value 62,660 50,931
Liability-classified restricted stock units vested 2,250 0
Deemed contribution from redemption of convertible preferred stock 12,679 0
Accrued tax withholding related to convertible preferred stock dividend $ 749 $ 0